All USA & Canada articles – Page 58
-
NewsNew tool helps identify babies at high risk for RSV
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
-
NewsChlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and those identifying as Black or multiracial
A recent study of individuals ages 15 to 60 has found that nearly one in five patients with chlamydia and one in four patients with gonorrhea did not receive CDC recommended treatment for their infection.
-
NewsLower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to new findings.
-
NewsThe rise of microbial cheaters in iron-limited environments
Competition and cooperation are fundamental forces that govern the evolutionary and ecological dynamics among species. The balance between these forces varies across ecological contexts, with some environments favoring cooperative behaviors that promote mutual benefit, while others reward competitive strategies that maximize individual fitness. Among microbial communities, chemicals ...
-
NewsStudy confirms effectiveness of bivalent COVID-19 vaccine
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to a new study.
-
NewsTreatment for deadly superbug C. diff may be weakening
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research.
-
NewsExperimental NIH malaria monoclonal antibody protective in Malian children
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial.
-
News Antimicrobial-resistant hospital infections remain at least 12% above pre-pandemic levels, major US study finds
Despite progress in combating antimicrobial resistance (AMR) in the USA since its peak during the COVID-19 pandemic, hospital-acquired AMR infections remain well above pre-pandemic levels, according to a major new study examining AMR before, during, and after the COVID-19 pandemic in 120 US hospitals. Source: NIAID Colorized scanning ...
-
NewsWastewater plant yields giant viruses that infect deadly parasite
Researchers have discovered giant viruses that infect the single-celled organism Naegleria fowleri which ranks among the deadliest human parasites.
-
NewsClimate change linked surge in malaria transmission could be less than feared
Despite concerns about the potential impact of climate change on increasing malaria risk, there is still limited understanding of how temperature affects malaria transmission – until now.
-
NewsStudy finds artificial intelligence can develop treatments to prevent superbugs
Researchers developed an AI model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on how quickly the bacteria grow given certain perturbations.
-
NewsNew ultraviolet light air disinfection technology could help protect against healthcare infections and even the next pandemic
Low doses of a particular wavelength of ultraviolet light, known as far-UVC, can kill viruses and bacteria without the safety concerns of conventional ultraviolet light.
-
NewsStudy finds X’s community notes provide accurate, credible answers to vaccine misinformation
A new study finds X’s Community Notes has resulted in hundreds of millions of views of accurate and credible COVID-19 vaccine education, suggesting considerable potential for the correction of misinformation.
-
NewsVaccine candidate could fight antibiotic resistance
Scientists have announced several discoveries that will help the development of a carbohydrate-based vaccine for infections caused by Staphylococcus aureus and its “superbug” relative methicillin-resistant Staphylococcus aureus, or MRSA.
-
NewsWorld’s chocolate supply threatened by devastating virus
A rapidly spreading virus threatens the health of the cacao tree and the dried seeds from which chocolate is made, jeopardizing the global supply of the world’s most popular treat.
-
NewsCoral identified as oldest bioluminescent organism, suggesting new model of ancient ecology
Researchers have identified eight organisms with previously unknown luminosity. Using genetic findings, they estimated coral bioluminescence originated about 540 million years ago in the Cambrian period, making them the earliest bioluminescent organisms.
-
NewsLivestock abortion surveillance could protect livelihoods and detect emerging global pathogens
A study suggests timely reporting and investigating of livestock abortions is feasible in rural areas and can provide insights into emerging infectious diseases.
-
News‘Sunny day flooding’ increases fecal contamination of coastal waters
A new study finds that ‘sunny day flooding’, which occurs during high tides, increases the levels of fecal bacteria in coastal waters, suggesting policymakers and public health officials should be aware of potential risks associated with tidal flooding.
-
NewsSalmonella rates more prevalent in commercial poultry farm samples vs backyard farms
In a comparison of differently sized poultry farms, researchers at North Carolina State University found that rates of Salmonella in fecal and environmental samples were more prevalent on larger commercial farms than on smaller backyard farms.
-
NewsEngineers muffle invading pathogens with a ‘molecular mask’
Researchers are developing a hydrogel therapy that acts as a first line of defense against viruses and other biological threats. The peptides that make up this gel prevent viruses such as SARS-CoV-2 from attaching to and entering cells.